Cancer Research
Researchers from Denmark and the United States publish new studies and findings in the area of cancer
Published in Gene Therapy Weekly, July 13th, 2006
Study 1: According to a study from Denmark, targeted cancer gene therapy for small-cell lung cancer utilizes a novel promoter.
"The insulinoma-associated 1 (INSM1) gene is expressed exclusively during early embryonal development, but has been found re-expressed at high levels in neuroendocrine tumors. The regulatory region of the INSM1 gene is therefore a potential candidate for regulating expression of a therapeutic gene in transcriptionally targeted cancer gene therapy against neuroendocrine tumors," wrote N. Pedersen and colleagues, National University Hospital.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-07-13)
More Articles from Gene Therapy Weekly
- Gene Knockdown
Gene knockdown constructs generated with convergent H1 and U6 promoters - Hypertension
Genetic hypertension is ameliorated by specific kinase suppression - Orthopedics
Regulation of Runx2-stimulated osteogenesis can be induced - RNA Interference
Drosophila RNAi screen identifies specific kinases as nuclear factor regulators - RNA Research
Intracellular-diced dsRNA silences HCV RNA and overcomes genotypic variation - Apoptosis
Apoptosis detected using functionalized bimodal lipid-based contrast agents - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
